Literature DB >> 29965850

Trachoma elimination, approaching 2020.

Mostafa M Diab1, Richard C Allen2, Tamer I Gawdat3, Ahmed S Saif1.   

Abstract

PURPOSE OF REVIEW: To review current practices for trachoma treatment with a focus on recent studies, particularly those discussing trachoma trichiasis surgery. RECENT
FINDINGS: Azithromycin eye drops twice daily for 3 days may be as efficient as oral azithromycin in treating active trachoma. Facial cleanliness and environmental improvement programming should employ a variety of behavior change techniques to give sustained improvements. Posterior lamellar tarsal rotation carries a lower risk for trichiasis recurrence and is more effective in severe trachoma trichiasis than bilamellar tarsal rotation. Tarsoconjunctival incision can play a pivotal role in trichiaisis recurrence. Tarsus-sparing procedures continue to be refined with good success rates. Concurrent correction of lid abnormalities that commonly occur with trachoma trichiasis may maximize the result of surgery.
SUMMARY: Better understanding of the pathophysiology of trachoma and postoperative trichiasis recurrence is critical for effective trachoma control. Progressive tarsoconjunctival scarring in trachoma and high recurrence rates following tarsal rotation procedures raise the importance of adopting a procedure that spares tarsus/conjunctiva.

Entities:  

Mesh:

Year:  2018        PMID: 29965850     DOI: 10.1097/ICU.0000000000000504

Source DB:  PubMed          Journal:  Curr Opin Ophthalmol        ISSN: 1040-8738            Impact factor:   3.761


  2 in total

1.  Anterior Lamellar Recession versus Posterior Lamellar Tarsal Rotation for Lower Lid Trachomatous Trichiasis: A Randomized Controlled Trial.

Authors:  Fatma M Abdelaziz; Mahmoud Ahmed Kamal; Mohamed M Said; Mostafa M Diab
Journal:  Clin Ophthalmol       Date:  2020-07-22

2.  Antibiotics for trachoma.

Authors:  Jennifer R Evans; Anthony W Solomon; Rahul Kumar; Ángela Perez; Balendra P Singh; Rajat Mohan Srivastava; Emma Harding-Esch
Journal:  Cochrane Database Syst Rev       Date:  2019-09-26
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.